Clinical trial
The Vanguard Study: Testing a New Way to Screen for Cancer
NCT06995898
Study timeline
Study start (actual)2025-06-18Date precision: day
Registry last updated2026-10-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Bladder Carcinomaunresolved
Breast Carcinomaunresolved
Colorectal Carcinomaunresolved
Esophageal Carcinomaunresolved
Gastric Carcinomaunresolved
Liver Carcinomaunresolved
Lung Carcinomaunresolved
Malignant Solid Neoplasmunresolved
Ovarian Carcinomaunresolved
Pancreatic Carcinomaunresolved
Prostate Carcinomaunresolved
Interventions
Biospecimen CollectionPROCEDURE
Device UsageDEVICE
Multi-Cancer Detection TestPROCEDURE
Multi-Cancer Detection TestPROCEDURE
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
DetroitMichigan, United States2RichmondVirginia, United States2FairfaxVirginia, United States2Fort CollinsColorado, United States2St LouisMissouri, United States1ClevelandOhio, United States1DurhamNorth Carolina, United States1MinneapolisMinnesota, United States1DenverColorado, United States1Oklahoma CityOklahoma, United States1Chapel HillNorth Carolina, United States1BethesdaMaryland, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06995898 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.